Merck COVID-19 pill success slams Moderna shares, shakes up health care sector Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies. https://ift.tt/2YcvR8Z https://ift.tt/3F4Df6G Markets October 3, 2021 at 08:35AM
Post a Comment